Evidence map›Paper›PMID 42743319›Full record

ArticlePloS one2026

Spatial clustering of esophageal cancer in central Oromia, Ethiopia: A spatial autocorrelation and scan statistics analysis.

Teresa Kisi Beyen, Edom Seife, Biniyam Tefera Deressa, Girma Taye, Adamu Addissie

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Teresa Kisi BeyenDepartment of Public Health, College of Health Science, Arsi University, Asella, Ethiopia.ORCID https://orcid.org/0000-0002-2168-6887
Edom SeifeCollege of Health Science, Addis Ababa University, Addis Ababa, Ethiopia.
Biniyam Tefera DeressaAdama Hospital Medical College, Adama, Ethiopia.
Girma TayeDepartment of Preventive Medicine, School of Public Health, College of Health Science, Addis Ababa University, Addis Ababa, Ethiopia.ORCID https://orcid.org/0000-0002-5488-4636
Adamu AddissieGlobal & Planetary Health Working Group, Institute of Medical Epidemiology, Biostatistics and Informatics, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.ORCID https://orcid.org/0000-0003-4709-3606

Funding

Wellcome Trust
6 · The paper itself

Abstract

introductionIn Ethiopia, according to the GLOBOCAN 2022 report, there were 1,494 cases of esophageal cancer and 1,422 deaths attributed to the disease. The incidence and mortality of esophageal cancer are projected to increase to 3,210 and 3,057 cases by 2040, respectively. Approximately 68.3% of the cases were reported from the Arsi and Bale Zones, which also had the highest disease burden and mortality. Thus, undertaking a thorough study to identify hotspot areas for local preventative and control actions is important.

objectiveTo assess the spatial clustering of esophageal cancer in Central Oromia, Ethiopia.

methodsA cross-sectional study design was employed to investigate the spatial clustering of esophageal cancer patients. Data were collected from records of 367 patients who visited four hospitals (namely, Tikur Anbessa Specialized Hospital, Adama Hospital Medical College, Asella Teaching and Referral Hospital, and Meda Walabu University General Hospital) between April 3, 2019, and August 25, 2025. The kebele, woreda, and zone of each patient were collected from the records and linked to Ethiopian shapfiles obtained from the Ethiopian Space Science and Geospatial Institute (SSGI). The spatial inequality of esophageal cancer was measured using the Gini coefficient; while spatial autocorrelation was assessed using Moran's I. The risks within clusters were quantified using relative risk (RR) with its 95% confidence interval, as well as log-likelihood ratio (LLR) and p-values.

resultsThe annual incidence of esophageal cancer in the study area was 2.60 cases per 100,000 populations [95% CI: 2.34, 2.88]. The Gini coefficient revealed spatial inequality in the distribution of cases at both the district (G = 0.33; 95% CI: 0.24, 0.40) and kebele levels (G = 0.38; 95% CI: 0.33, 0.43). The Moran's I showd significant positive spatial autocorrelation at the kebele level (I = 0.17, p-value = 0.037). The risk of developing esophageal cancer was high in Robe district [RR = 1.93; 95% CI: 1.43, 2.61; LLR = 6.82; p-value = 0.022], Robe 01 kebele [RR = 7.8; 95% CI: 4.57, 13.31; LLR = 16.35; p-value = 0.000024], and Kula 01 kebele [RR = 9.96; 95% CI: 4.45, 22.32; LLR = 8.35; p-value = 0.034]. In contrast, 17 districts [RR = 0.55; 95% CI: 0.41, 0.73; LLR = 9.31; p-value = 0.0051] and 52 kebeles [RR = 0.55; 95% CI: 0.41, 0.73; LLR = 0.87; p-value = 0.014] were identified as low-risk areas. CONCLUSION AND RECOMMENDATION: Esophageal cancer showed uneven spatial distribution and significant autocorrelation in the study area. The presence of both high- and low-risk areas indicated significant geographic disparities. Robe district had nearly twice the risk, Robe 01 kebele had more than seven times the risk, and Kula 01 kebele had nearly ten times the risk of developing esophageal cancer compared to other districts and kebeles, respectively. Allocating diagnostic resources to health facilities serving high-risk districts and kebeles, promoting community health education on modifiable risk factors, and investigating individual-level risk factors are required to explain the observed clustering patterns.

Indexed as

Esophageal NeoplasmsAdultAgedCluster AnalysisCross-Sectional StudiesEthiopiaFemaleHumansIncidenceMaleMiddle AgedSpatial Analysis

Identifiers

PMID42743319
PMCPMC13577588

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.